Phoenix, Arizona
Exosome supply and 503A pharmacy access for Phoenix practices
ExaVeyra supplies research-use exosome material to licensed practices in Phoenix from its base in Miami Beach, and because Arizona is a state where the 503A pharmacy partner holds a non-resident license, a prescriber here can also send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly. This page covers what a practice in Maricopa County can source, how cold-chain material arrives, and where the Arizona law questions are answered.
It speaks to the practice, names no condition or use, and leaves delegation and statute to the Arizona sourcing guide.
What a Phoenix practice can source
| Material | Availability here |
|---|---|
| Exosome material | Available. Research-use exosome formats, characterised per lot, shipped cold-chain from Miami Beach to licensed practices in every state and Puerto Rico. |
| Compounded 503A preparations | Available. Prepared to an individual prescription by our 503A pharmacy partner, which holds a non-resident pharmacy license for Arizona, and dispensed by that pharmacy to the patient named on the prescription. |
| Documentation | A lot-specific certificate of analysis is available on request for every exosome lot; compounded preparations carry the pharmacy label and beyond-use date. |
The practice landscape in Phoenix
The clinical centre of Phoenix is the medical district east of downtown, where Banner University Medical Center Phoenix on East McDowell Road, Dignity Health St. Joseph's Hospital and Medical Center with the Barrow Neurological Institute on West Thomas Road, and Phoenix Children's Hospital on East Thomas Road sit within a short drive of one another, and where the city-owned Phoenix Bioscience Core downtown houses the University of Arizona College of Medicine Phoenix and its research tenants. The medical office plazas along McDowell and Thomas roads carry the hospital-affiliated specialists, and a practice there receives at a staffed suite inside a multi-tenant building with a shared dock. Mayo Clinic's hospital campus on East Mayo Boulevard in the north of the city borders Scottsdale and is described on the Scottsdale page.
The Biltmore corridor along East Camelback Road between 24th and 32nd streets is where the city's private aesthetic, dermatology and plastic surgery practices concentrate, in the office towers of the Esplanade and Biltmore Center and in the low-rise medical plazas along 32nd Street and Campbell Avenue. Arcadia, east of the corridor toward 44th Street, adds a residential population and the physician-owned practices in converted retail and small office buildings that serve it, and concierge, hormone-optimization and longevity practices have taken suites along the same Camelback spine. The gated streets of the Arizona Biltmore Estates north of Camelback Road put a residential clientele within walking distance of the corridor. A delivery address here is typically a suite in a tower with a ground-floor dock and a mail room, so the account records whether the carrier delivers to the dock or to the suite door and who signs at each.
Southeast of the city the East Valley carries its own practice base. Chandler Regional Medical Center on South Dobson Road and Mercy Gilbert Medical Center on South Val Vista Drive anchor a medical office corridor that has followed the Price Road employment district, where Intel and other technology employers sit at the junction of Loop 101 and Loop 202, and Banner Gateway Medical Center in Gilbert adds a third hospital campus along Higley Road. Practices in Chandler and Gilbert tend toward newer single-storey medical office parks with suite-level receiving and surface parking, and Tempe, between them and the city, adds the Arizona State University campus population and the practices around it. Each is a Maricopa County address on the same lane as the city.
Phoenix Sky Harbor International Airport sits between downtown and Tempe and is the carrier air gateway for the metro, with FedEx and UPS both operating from the airport's cargo complexes, so an air shipment from Miami Beach lands close to every address on this page. Two calendars shape a Phoenix practice's ordering: the winter residents who arrive from October and leave by April or May, when aesthetic and concierge schedules run fullest, and the summer, when afternoon heat in the city makes an unattended loading dock the wrong place for a cold-chain package to wait. The receiving procedure on the cold-chain page applies with particular weight from June through September, and the account names a staff member who is present on the delivery day and will move the package indoors on arrival.
The hair and scalp literature, for Phoenix practices
The hair and scalp series on this site sets out, component by component, what the peer-reviewed literature and the FDA say about each formulation class the literature discusses. What follows is what that means for sourcing in this market.
The hair and scalp series on this site is the evidence reference for each formulation class the literature discusses, and for a Phoenix practice the sourcing position is that research-use exosome formats are supplied on the practice's verified account, and the compounded preparations the pharmacy partner prepares are dispensed by that pharmacy against individual prescriptions, so the two travel separately under their own regimes. The evidence pages set out the literature and the FDA communications for each component, and the product category lists what the pharmacy partner prepares to prescription.
In Phoenix the question a practice tends to raise is a seasonal one: a group that adds hours or opens a second site for the winter months asks whether a prescription written at one site is dispensed any differently from one written at another, and the answer is that the pharmacy partner verifies the prescriber's Arizona license, and the address on the prescription is a delivery detail. The nurse-practitioner-led practices along the Camelback corridor also ask what an NP may prescribe and under what collaboration, and those are questions the Arizona Medical Board and the Arizona State Board of Nursing answer; the Arizona sourcing guide links both.
How material reaches Phoenix
Cold-chain shipments dispatch from the Miami Beach facility under continuous temperature monitoring and reach Arizona practices in 1 to 3 business days, scheduled to avoid a weekend hold at the carrier hub.
Arizona law is a separate question, answered in the state guide
What a Arizona practice may offer, who in the practice may handle material, whether the state has a stem cell or regenerative-medicine statute and how any such statute reads against an acellular preparation, and which boards verify a license are covered in the Arizona sourcing guide rather than repeated here. Nothing about the city changes any of it.
Phoenix sourcing questions
- How does cold-chain material reach a Phoenix practice?
- Shipments dispatch from Miami Beach under validated temperature monitoring and route through the carrier air network into Phoenix Sky Harbor, then by ground to the address on file. The Arizona guide states the transit range. Dispatch is timed so a package does not hold at a hub over a weekend, and in summer the account names who takes it indoors on arrival.
- Can a Phoenix practice source both exosome material and compounded preparations?
- Yes. Arizona is a state where the 503A pharmacy partner holds a non-resident pharmacy license, so a prescriber here can send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly, and research-use exosome material ships to any licensed practice. The two are handled under separate regimes and never share a shipment or a stocking calendar.
- Are Chandler, Gilbert and Tempe served the same way as Phoenix?
- Yes. Each is a Maricopa County address on the same Arizona lane, and a group with a Biltmore office and a second site in Gilbert lists both addresses on a single account so a lot traces to the site that received it. What changes is the building: a Camelback tower receives through a dock and a mail room, an East Valley office park at the suite door, and the account records which applies.
Sources
- Arizona Medical Board (accessed 17 September 2026)
- Arizona State Board of Pharmacy (accessed 17 September 2026)
- City of Phoenix, official site (accessed 17 September 2026)
Last reviewed 17 September 2026 by Benn Bluestein-Veyra, M.Sc. Organic Chemistry. Availability is read from the state registry at the time of the request.
These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Exosome material distributed by ExaVeyra Sciences is supplied for Research Use Only, for medical, molecular biology, and biochemistry research applications, and ExaVeyra Sciences makes no statement about administration, route, or outcome. Compounded medications are a separate product class: they are not FDA-approved finished drug products, they are prepared under section 503A of the Federal Food, Drug, and Cosmetic Act against a prescription for an individual patient, and they are prescription products rather than research-use-only material. ExaVeyra does not supply controlled substances. This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. The FDA has not approved GHK-Cu or any exosome product for hair loss or any form of alopecia. Compounded medications are not FDA-approved; they are prepared by a licensed 503A compounding pharmacy for an individual patient against that patient’s prescription, and they are supplied to NPI-verified licensed practitioners only. Where this page discusses an FDA-approved active such as oral finasteride or topical minoxidil, the approved product’s labeling governs and nothing here modifies it. ExaVeyra Sciences is a supplier and takes no part in any diagnosis, treatment decision, or plan of care. ExaVeyra Sciences does not supply controlled substances. Findings described on this page are attributed to the peer-reviewed literature and to the agencies cited, and a citation establishes that a question was studied, not that any product is suitable for a given patient. The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here. Exosome material is supplied for Research Use Only. No exosome product is FDA-approved for any use, and ExaVeyra Sciences makes no statement about administration, route, or outcome.
Reference only. Not legal or medical advice.
The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here.
Read the full disclaimer
ExaVeyra Sciences publishes these guides as a reference for licensed practitioners. They summarize publicly available federal and state requirements as those requirements read on the review date shown above. The content is provided for general informational purposes only and does not constitute legal, medical, or regulatory advice, and it does not establish that any particular product or practice is compliant.
No attorney-client relationship, and no professional or clinical relationship of any kind, is created by accessing these materials. ExaVeyra Sciences is a supplier of research-use materials. It is not a law firm, it is not a regulatory consultant, and it takes no part in any diagnosis, treatment decision, or plan of care. Each practitioner is responsible for retaining their own legal counsel and for determining, with that counsel and the applicable state licensing boards, how the requirements described here apply to the services, staffing, and structure of their own practice.
Statutes, regulations, board rules, and agency positions are subject to amendment, supersession, and reinterpretation. ExaVeyra Sciences makes no representation or warranty as to the accuracy, completeness, timeliness, or applicability of this content to any particular practice. Citations and links to third-party sources are provided for convenience only and do not constitute an endorsement of their content.
The practitioner and the practice are solely responsible for compliance with all applicable licensing, scope of practice, supervision, ownership, facility, recordkeeping, and tax requirements, and for all clinical decisions, including the suitability of any material for a given patient. To the fullest extent permitted by law, ExaVeyra Sciences disclaims all liability for any action taken or not taken in reliance on this content.